President Donald Trump announced that his administration would tackle rising drug costs in the United States by establishing “most favored nation” pricing, which would base the U.S. prices of pharmaceuticals on the lowest prices paid by other foreign nations.

President Donald Trump said at a White House press conference that the US would "no longer tolerate profiteering and price gouging from Big Pharma."